Why Cameco Could Be One of the Biggest Winners in America's Nuclear Renaissance

Cameco (CCJ), which supplies roughly 17% of global uranium and owns a 49% stake in Westinghouse, reported Q3 2025 revenue down 15% YoY to $441.7 million with EBITDA declining 5% and a small loss per share driven by Canadian production issues, though uranium production rose 2% for the quarter. Year-to-date through nine months 2025 revenue is up 17%, EBITDA up 33% and EPS up 203% YoY, supporting a stronger full-year outlook. A U.S. administration-backed $80 billion program to build Westinghouse AP1000 reactors, combined with a ban on Russian uranium and favourable Canada–U.S. trade positioning, materially improves Cameco’s addressable market and underpins a constructive medium-term investment case.

Analysis

Market structure: The US $80bn reactor program and Russian-uranium exclusions re-route incremental demand to Western producers, raising medium-term pricing power for vertically integrated players (Cameco + Westinghouse). Expect tighter long-term uranium curves and higher contracting volumes over 12–60 months, while spot volatility will remain high as traders arbitrage inventory and secondary supplies.

Risk assessment: Key tail risks are regulatory/permit delays on Canadian mines, cost-overruns at AP1000 builds, and a diplomatic reset that reopens Russian supply — any of which could wipe out >30% of implied upside in 6–24 months. Near-term (days-weeks) price moves will be headline-driven; material fundamental shifts will emerge over quarters as US contracting cadence and Canadian production guidance update.

Trade implications: Favor concentrated, staged exposure to CCJ: tactical 2–3% long position with staggered scale-ups tied to DOE/RFQ milestones over 6–18 months. Use options to define risk — sell cash-secured puts 10–15% OTM to accumulate below current levels and buy 18-month LEAP calls to capture policy-driven re-rating; add 1–2% URA exposure for pure commodity beta and hedge via 1–2% short in gas-heavy utilities to play fuel-switch risk.

Contrarian angle: Consensus prices in smooth execution; the market underestimates integration and capital demands from Westinghouse, which could compress Cameco free cash flow if capex/working capital overruns occur. If uranium spot rallies >50% without concurrent contracting, mean reversion is likely; conversely, a slow but steady contracting cadence could deliver asymmetric upside over 12–36 months.

Key Decisions for Investors

• Establish a 2–3% long position in CCJ now, scale to 5% only upon DOE/AP1000 contract awards or confirmation of multi-year US contracting (monitor announcements next 3–9 months); set stop-loss at 15% and target 35–50% upside over 12–24 months.
• Buy 18-month CCJ LEAP calls (near-ATM) equal to 50% of intended exposure and fund with selling 10–15% OTM cash-secured puts to lower basis; close or roll if implied vol rises >40% or after material DOE contracting (30–90 days post-announcement).
• Allocate 1–2% portfolio to URA (uranium ETF) for commodity beta and hedge with a 1% short position in a gas-heavy utility ETF (e.g., XLU overweight gas names) to capture fuel-switch tailwinds; rebalance when URA up >40% or uranium spot >$90/lb.
• Avoid leveraged long exposure to Westinghouse equity/stakes until site-level EPC contracts and fixed-price schedules are public (monitor US Treasury/DOE procurement calendar over next 6 months); reassess if capex guidance increases by >20%.